Sam Butterworth
Founding scientist
Slingshot Therapeutics
This startup provides a platform that accelerates early-stage biotechnological research towards drug development. It offers infrastructure, sector expertise, and financial backing to academic founders, helping them advance scientific breakthroughs into clinical readiness.
- Biotechnology
Updated 6 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Problem
Early-stage academic drug discovery often faces challenges in progressing from initial scientific breakthroughs to clinical readiness due to a complex biotech landscape. Academic founders may lack the necessary sector expertise, operational infrastructure, and financial backing to navigate preclinical development effectively. This can result in promising scientific discoveries failing to reach their full potential as impactful therapies.
Solution
Slingshot is a medicines accelerator focused on unlocking the potential of academic drug discovery, particularly in the realm of small molecules. The company identifies high-potential breakthroughs within the scientific ecosystem and provides a platform to advance early-stage science towards drug development. Slingshot offers sector expertise, operational infrastructure, and financial backing to academic founders, enabling them to progress their ideas through preclinical stages and prepare them for clinical trials. By focusing on hypothesis-driven science with clear development pathways and significant unmet medical needs, Slingshot aims to transform innovative discoveries into tangible, breakthrough medicines.
Target Audience
Slingshot primarily targets academics and pharmaceutical companies seeking to translate early-stage scientific discoveries into clinically ready drug candidates.
Features
- Identification of promising early scientific opportunities with a focus on small molecules.
- Provision of sector expertise, operational infrastructure, and financial backing.
- Proactive program planning and risk management.
- Multidisciplinary approach to program progression, built around the founding science.
- Structured milestones and program governance.
- Guidance and support for informed decision-making throughout the development process.
- Assistance in securing groundbreaking early science discoveries from world-class scientists and key opinion leaders.
- Development of robust target product profiles and execution of clear, structured drug development plans.